US FDA accepts for priority review Bristol Myers Squibb’s sBLA for Breyanzi to treat adult patients with relapsed or refractory MZL: Princeton, New Jersey Wednesday, August 6, 2 ...

Based on positive Phase II TRANSCEND FL data showing a 95.5% overall response rate, the FDA has accepted Bristol Myers Squibb’s sBLA for Breyanzi in relapsed or refractory MZL with a PDUFA date set ...

Going out to eat? See which Collier County restaurants were rated best by inspectors, and which failed the test.

The Primary Cart includes your top choices. Think of it like the schedule you want the most! Courses saved in your Alternatives Cart will be available to select in your Primary Cart as an alternate ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

AdventHealth has blasted Mission Hospital’s request for the North Carolina Supreme Court to reconsider a lower court’s decision to award it 67 hospital beds, saying in an Aug. 1 court filing that the ...

Going out to eat? See which Indian River County restaurants were rated best by inspectors, and which failed the test.

Two victims of Jeffrey Epstein’s sex trafficking ring blasted the Trump administration over the notorious case Monday, with one accusing the Justice Department of prioritizing protection of the dead ...

Explore the best internet service providers in Sacramento including Xfinity, AT&T, Verizon 5G, T-Mobile and Hughesnet.

The U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for AstraZeneca’s supplemental Biologics ...

The Trump administration’s announcement of a panoply of steep tariffs on April 2, 2025, and the associated tariff negotiations that followed, has been met with extensive media coverage and analysis.

The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue ...